Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited’s U.S. subsidiary, Visage Imaging, has secured a A$53 million, 7-year contract with BayCare, a prominent healthcare system in Florida. This agreement marks a significant expansion into the North American integrated delivery network market, utilizing the company’s cloud-based Visage 7 Enterprise Imaging Platform to enhance diagnostic imaging services across BayCare’s extensive network. This deal underscores Pro Medicus’s strategic focus on cloud-based solutions in the healthcare IT market, reinforcing its position as a leader in medical imaging technology.
More about Pro Medicus Limited
Pro Medicus Limited is a leading healthcare informatics company founded in 1983. It provides a comprehensive range of medical imaging software and services to hospitals, imaging centers, and healthcare groups globally. The acquisition of Visage Imaging in 2009 has positioned Pro Medicus as a global provider of advanced medical imaging solutions.
YTD Price Performance: 6.81%
Average Trading Volume: 351
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $17.8B
See more insights into PME stock on TipRanks’ Stock Analysis page.
